Training Manual for Preventive Malaria - Ministry of Health

WHO SHOULD REPORT ADRS IN GHANA FOR SP IN IPT
• The patient (usually to the CBS/CHO/MCH Centre/Health Centre/ Hospital).
• Community Based Supports (CBSs)
• Health care workers (e.g. Clinic attendants)
Health professionals should fill the SP/IPT reporting form on behalf of patients and submit it
to the next level.
WHAT SHOULD BE REPORTED?
All suspected reactions to SP on SP/IPT forms and all drugs on National Reporting Form – blue
colour, including minor ones.
In addition, drug-drug, drug-food, or drug-food supplements interactions (including herbal and
complementary products) should also be reported.
The following should also be reported;
• Overdose or medication error
• Lack of efficacy or when the drug is suspected to be defective, substandard, counterfeit or
not giving the “expected” response.
• Any other reaction that the patient is sufficiently concerned about to report to the health
professional. Remember “if the patient is concerned enough to report a reaction to you, you
must also be concerned to report to the NMCP/NCPv.
ADVERSE EVENT REPORTING FORM (specimen at the appendix)
A copy of the National Spontaneous Reporting Form is shown in Appendix. The form consists
four main parts as follows:
Patient Details
Name
Age, Weight
Address
Reaction Details
What happened – description of the event or problem
When – date of event
What was done – treatment given to the patient or whether the drug was withdrawn
(dechallenge) and/or reintroduced (rechallenge)
What was the outcome – outcomes attributed to adverse event i.e. was the patient
hospitalized? If so, for how long? Did the patient die? How long did the reaction last?
Drug Details
o Suspected agent (brand names if known or else generic name)
o Lot/batch number, expiry date etc. if known
o Dose, frequency and route used
o Date of intake
o Was patient on SP for IPT?
58